blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2997373

EP2997373 - RECEPTORS FOR B7-H4 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.12.2016
Database last updated on 28.09.2024
Most recent event   Tooltip23.12.2016Application deemed to be withdrawnpublished on 25.01.2017  [2017/04]
Applicant(s)For all designated states
MedImmune, LLC
One MedImmune Way
Gaithersburg, MD 20878 / US
[2016/12]
Inventor(s)01 / LANGERMANN, Solomon
6606 Cross Country Blvd.
Baltimore, MD 21215 / US
02 / PODOJIL, Joseph R.
4533 Saratoga Avenue
Downers Grove, IL 60515 / US
03 / MILLER, Stephen D.
946 Gunderson Avenue
Oak Park, IL 60304 / US
 [2016/12]
Representative(s)Johnson, Yvonne Catherine
Barker Brettell LLP
100 Hagley Road
Edgbaston
Birmingham
B16 8QQ / GB
[2016/12]
Application number, filing date14730049.519.05.2014
[2016/12]
WO2014US38623
Priority number, dateUS201361824860P17.05.2013         Original published format: US 201361824860 P
[2016/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014186798
Date:20.11.2014
Language:EN
[2014/47]
Type: A1 Application with search report 
No.:EP2997373
Date:23.03.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 20.11.2014 takes the place of the publication of the European patent application.
[2016/12]
Search report(s)International search report - published on:EP20.11.2014
ClassificationIPC:G01N33/564, A61K38/00, A61K39/00, G01N33/68
[2016/12]
CPC:
G01N33/564 (EP,US); A61K38/1709 (EP,US); A61K38/177 (EP,US);
A61K38/1774 (EP,US); C07K14/70532 (US); C07K14/71 (US);
C07K16/2827 (US); C12N15/1138 (US); G01N33/6893 (EP,US);
A61K38/00 (US); C07K2317/76 (US); C07K2319/30 (US);
G01N2333/70532 (EP,US); G01N2800/24 (EP,US); G01N2800/245 (EP,US);
G01N2800/52 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/12]
TitleGerman:REZEPTOREN FÜR B7-H4[2016/12]
English:RECEPTORS FOR B7-H4[2016/12]
French:RÉCEPTEURS POUR B7-H4[2016/12]
Entry into regional phase08.12.2015National basic fee paid 
08.12.2015Designation fee(s) paid 
08.12.2015Examination fee paid 
Examination procedure08.12.2015Examination requested  [2016/12]
02.08.2016Application deemed to be withdrawn, date of legal effect  [2017/04]
02.08.2016Loss of particular rights, legal effect: Claims
08.09.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time  [2017/04]
08.09.2016Despatch of communication of loss of particular rights: Claims {1}
Fees paidPenalty fee
Additional fee for renewal fee
31.05.201603   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]WO9929858  (CHILDRENS MEDICAL CENTER [US], et al) [X] 12-15 * claims 1-9; abstract * [I] 16-20;
 [XI]WO9955855  (GENESENSE TECHNOLOGIES INC [CA], et al) [X] 30,32,34-38,40-55 * Claims; page 35, par 3 * [I] 31,33,39;
 [X]WO2007009816  (STICHTING KATHOLIEKE UNIV [NL], et al) [X] 7-9* abstact; claims *;
 [XD]US2008206235  (CHEN LIEPING [US]) [XD] 12,13,21-29,40-55 * Claims *;
 [XDI]US2009142342  (CHEN LIEPING [US]) [XD] 56-63,71-97,99 * Claims * [I] 69,70,98;
 [XI]WO2011026122  (AMPLIMMUNE INC [US], et al) [X] 56-63,71-97,99 * Figure 1a; abstract; claims 1-30 * [I] 69,70,98;
 [A]US2012039883  (CHEN LIEPING [US]) [A] 1-11 * Claims; paragraphs 59-79 *;
 [XI]WO2013025779  (AMPLIMMUNE INC [US], et al) [X] 12,13,23,40-56,64-68,76-82 * Claims * [I] 24-29,39,69,70;
 [A]  - XIAOJIE WANG ET AL, "B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation", PLOS ONE, (20120104), vol. 7, no. 1, doi:10.1371/journal.pone.0028232, page e28232, XP055134288 [A] 1-99 * the whole document *

DOI:   http://dx.doi.org/10.1371/journal.pone.0028232
 [A]  - JANELLE M. FAUCI ET AL, "A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer", GYNECOLOGIC ONCOLOGY, (20121101), vol. 127, no. 2, doi:10.1016/j.ygyno.2012.08.017, ISSN 0090-8258, pages 420 - 425, XP055134637 [A] 1-99 * Table 1 ; abstract *

DOI:   http://dx.doi.org/10.1016/j.ygyno.2012.08.017
by applicantUS5120727
 US5162333
 US5202332
 US5283173
 US5385908
 WO9504738
 WO9516691
 WO9522972
 US5484790
 US5530006
 US5559112
 US5567709
 US5780462
 US5821333
 WO9856401
 US5932448
 US5989591
 WO0001385
 US6015809
 WO0100814
 WO0244321
 US6562576
 US6673545
 US6677157
 US6699475
 US6790624
 US2008206235
 WO2009005352
 US2009142342
 US7931896
 US7989173
 US2012177645
 US2012276095
    - LENSHOW ET AL., ANNU. REV. IMMUNOL., (1996), vol. 14, pages 233 - 258
    - CHAMBERS; ALLISON, CURR. OPIN. IMMUNOL., (1997), vol. 9, pages 396 - 404
    - RATHMELL; THOMPSON, ANNU. REV. IMMUNOL., (1999), vol. 17, pages 81 - 828
    - KRUMMEL; ALLISON, J. EXP. MED., (1996), vol. 183, pages 2533 - 2540
    - WALUNAS ET AL., J. EXP. MED., (1996), vol. 183, pages 2541 - 2550
    - DONG ET AL., NATURE MED., (1999), vol. 5, pages 1365 - 1369
    - FREEMAN ET AL., J. EXP. MED., (2000), vol. 192, pages 1 - 9
    - TSENG ET AL., J. EXP. MED., (2001), vol. 193, pages 839 - 846
    - LATCHMAN ET AL., NATURE IMMUNOL., (2001), vol. 2, pages 261 - 268
    - WANG ET AL., BLOOD, (2000), vol. 96, pages 2808 - 2813
    - SWALLOW ET AL., IMMUNITY, (1999), vol. 11, pages 423 - 432
    - YOSHINAGA ET AL., NATURE, (1999), vol. 402, pages 827 - 832
    - CHAPOVAL ET AL., NATURE IMMUNOL., (2001), vol. 2, pages 269 - 274
    - CHOI ET AL., J. IMMUNOL., (2003), vol. 171, pages 4650 - 4654
    - SICA ET AL., IMMUNITY, (2003), vol. 18, pages 849 - 861
    - PRASAD ET AL., IMMUNITY, (2003), vol. 18, pages 863 - 873
    - ZANG ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2003), vol. 100, pages 10388 - 10392
    - ZHU ET AL., NATURE COMM.
    - BRANDT ET AL., J EXP MED., (20090706), vol. 206, no. 7, pages 1495 - 503
    - DONG ET AL., IMMUNOL. RES., (2003), vol. 28, pages 39 - 48
    - PRASAD, IMMUNITY, (2003), vol. 18, pages 863 - 873
    - PRUD'HOMME ET AL., ONCOTARGET, (2012), vol. 3, pages 921 - 939
    - YAMAMOTO ET AL., INTERNATIONAL IMMUNOLOGY, (2008), vol. 20, no. 3, pages 413 - 420
    - ELLIS, L., MOL CANCER THER, (2006), vol. 5, page 1099
    - NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, pages 443 - 453
    - PROC. NATL. ACAD. SCI. U.S.A., (1992), vol. 89, pages 10915 - 10919
    - CHAPOVAL ET AL., METHODS MOL. MED., (2000), vol. 45, pages 247 - 255
    - VIDAL ET AL., BIOCHEMISTRY, (2004), vol. 43, pages 7336 - 44
    - ZHOU ET AL., NATURE, (1995), vol. 378, pages 584 - 592
    - SUDOL, PROG. BIOCHYS. MOL. BIO., (1996), vol. 65, pages 113 - 132
    - KIM ET AL., NATURE, (1995), vol. 378, pages 85 - 88
    - KOMAU ET AL., SCIENCE, (1995), vol. 269, pages 1737 - 1740
    - HU ET AL., J. BIOL. CHEM., (1998), vol. 273, pages 33489 - 33494
    - ARAKAWA ET AL., J. BIOL. CHEM., (1994), vol. 269, no. 45, pages 27833 - 27839
    - RADZIEJEWSKI ET AL., BIOCHEM., (1993), vol. 32, no. 48, page 1350
    - KATAHIRA ET AL., J. BIOL. CHEM., (2002), vol. 277, pages 9242 - 9246
    - GUO, EMBO J., (1998), vol. 17, pages 5265 - 5272
    - MALASHKEVICH ET AL., SCIENCE, (1996), vol. 274, pages 761 - 765
    - SIMON ET AL., CANCER RES., (2006), vol. 66, no. 3, pages 1570 - 5
    - AZUMA ET AL., PLOS MED., (20091020), vol. 6, no. 10, page E1000166
    - WOLFF ET AL., CANCER RES., (1993), vol. 53, pages 2560 - 2565
    - FIRE, A. ET AL., NATURE, (1998), vol. 391, pages 806 - 11
    - NAPOLI, C. ET AL., PLANT CELL, (1990), vol. 2, pages 279 - 89
    - HANNON, G.J., NATURE, (2002), vol. 418, pages 44 - 1
    - ELBASHIR, S.M. ET AL., GENES DEV., (2001), vol. 15, pages 188 - 200
    - BERNSTEIN, E. ET AL., NATURE, (2001), vol. 409, pages 363 - 6
    - HAMMOND, S.M. ET AL., NATURE, (2000), vol. 404, pages 293 - 6
    - NYKANEN, A. ET AL., CELL, (2001), vol. 107, pages 309 - 21
    - MARTINEZ, J. ET AL., CELL, (2002), vol. 110, pages 563 - 74
    - ELBASHIR, S.M. ET AL., NATURE, (2001), vol. 411, pages 494 - 498
    - UI-TEI, K. ET AL., FEBS LETT, (2000), vol. 479, pages 79 - 82
    - WOLFF ET AL., CANCER RES., vol. 53, pages 2560 - 2565
    - MATHIOWITZ; LANGER, J. CONTROLLED RELEASE, (1987), vol. 5, pages 13 - 22
    - MATHIOWITZ ET AL., REACTIVE POLYMERS, (1987), vol. 6, pages 275 - 283
    - MATHIOWITZ ET AL., J. APPL. POLYMER SCI., (1988), vol. 35, pages 755 - 774
    - Remington's Pharmaceutical Sciences, LIPPINCOTT, WILLIAMS & WILINS, (2005), pages 889 - 964
    - MOORE ET AL., CHEM. REV., (2001), vol. 101, no. 12, pages 3893 - 4012
    - GENTILUCCI ET AL., CURR. MED. CHEM, (2006), vol. 13, no. 20, pages 2449 - 66
    - SARRIS ET AL., IMMUNITY, (2008), vol. 28, pages 402 - 413
    - SHEVACH, IMMUNITY, (2009), vol. 30, pages 636 - 645
    - SOLOMON ET AL., PNAS, (2011), vol. 108, no. 5, pages 2040 - 2045
    - XQ ET AL., SCAND J RHEUMATOL., (2012), vol. 41, pages 413 - 420
    - HANSEN, ONCOIMMUNOLOGY, (2013), vol. 2:2, page E23039
    - BALKWILL, F. ET AL., "Inflammation And Cancer: Back To Virchow?,", LANCET, (2001), vol. 357, pages 539 - 545
    - COUSSENS, L. M. ET AL., "Inflammation and Cancer,", NATURE, (2002), vol. 420, pages 860 - 867
    - ALLAVENA, P. ET AL., "Pathways Connecting Inflammation and Cancer,", CURR. OPIN. GENET. DEVEL., (2008), vol. 18, page 10
    - COLOTTA, F., "Cancer-Related Inflammation, The Seventh Hallmark of Cancer: Links to Genetic Instability,", CARCINOGENESIS, (2009), vol. 30, no. 7, pages 1073 - 1081
    - PORTA, C. ET AL., "Cellular and Molecular Pathways Linking Inflammation and Cancer,", IMMUNOBIOLOGY, (2009), vol. 214, pages 761 - 777
    - SOLINAS, G. ET AL., "Tumor-Associated Macrophages (TAM) As Major Players Of The Cancer-Related Inflammation,", J. LEUKOC. BIOL., (2009), vol. 86, no. 5, pages 1065 - 1073
    - POLLARD, J.W., "Trophic Macrophages In Development And Disease,", NAT. REV. IMMUNOL., (2009), vol. 9, pages 259 - 270
    - FARINHA, P. ET AL., "Analysis Of Multiple Biomarkers Shows That Lymphoma-Associated Macrophage (LAM) Content Is An Independent Predictor Of Survival In Follicular Lymphoma (FL)", BLOOD, (2005), vol. 106, pages 2169 - 2174
    - DAVE, S.S. ET AL., "Prediction Of Survival In Follicular Lymphoma Based On Molecular Features Of Tumor-Infiltrating Immune Cells,", N. ENGL. J. MED., (2004), vol. 351, pages 2159 - 2169
    - KRYCZEK, 1. ET AL., "B7-H4 Expression Identifies A Novel Suppressive Macrophage Population In Human Ovarian Carcinoma,", J. EXP. MED., (2006), vol. 203, no. 4, pages 871 - 881
    - KRYCZEK, I. ET AL., "Relationship Between B7-H4, Regulatory T Cells, And Patient Outcome In Human Ovarian Carcinoma,", CANCER RES., (2007), vol. 67, no. 18, pages 8900 - 8905
    - KALER, P. ET AL., "Tumor Associated Macrophages Protect Colon Cancer Cells from TRAIL-Induced Apoptosis through IL-lfl-Dependent Stabilization of Snail in Tumor Cells,", PLOS ONE, (2010), vol. 5, no. 7, pages E11700 1 - 13
    - ZAMARRON, B.F. ET AL., "Dual Roles Of Immune Cells And Their Factors In Cancer Development And Progression,", INT. J. BIOL. SCI., (2011), vol. 7, no. 5, pages 651 - 658
    - LIU, J. ET AL., "Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells And Promote The Development Of Colorectal Cancer Via Enhancing CCL20 Production In Mice,", PLOS ONE., (2011), vol. 6, no. 4, page E19495
    - RIGO, A. ET AL., "Macrophages May Promote Cancer Growth Via A GM-CSF/HB-EGF Paracrine Loop That Is Enhanced By CXCLl2,", MOLEC. CANCER, (2010), vol. 9, no. 273, pages 1 - 13
    - LIN, J.Y. ET AL., "Clinical Significance Of Tumor-Associated Macrophage Infiltration In Supraglottic Laryngeal Carcinoma,", CHIN. J. CANCER, (2011), vol. 30, no. 4, pages 280 - 286
    - VERGATI, M., "The Consequence Of Immune Suppressive Cells In The Use Of Therapeutic Cancer Vaccines And Their Importance In Immune Monitoring,", J. BIOMED. BIOTECHNOL., (2011), page 182413
    - KRYCZEK, I. ET AL., "B7-H4 Expression Identifies A Novel Suppressive Macrophage Population In Human Ovarian Carcinoma,", J. EXP. MED., (2006), vol. 203, no. 4, pages 871 - 881
    - KRYCZEK, I. ET AL., "Cutting Edge: Induction Of B7-H4 On APCs Through IL-10: Novel Suppressive Mode For Regulatory T Cells,", J. IMMUNOL., (2006), vol. 177, no. 1, pages 40 - 44
    - JAGER ET AL., INT. J. CANCER, (2003), vol. 106, pages 817 - 20
    - KENNEDY ET AL., INT. REV. IMMUNOL., (2003), vol. 22, pages 141 - 72
    - SCANLAN ET AL., CANCER IMMUN., (2004), vol. 4, page 1
    - BROWN ET AL., J. IMMUNOL., (1981), vol. 127, pages 539 - 46
    - ROSE ET AL., PROC. NATL. ACAD. SCI. USA, (1986), vol. 83, pages 1261 - 61
    - MCMANUS ET AL., CANCER RES., (1976), vol. 36, pages 3476 - 81
    - YOSHIMURA ET AL., CANCER, (1994), vol. 73, pages 2745 - 52
    - YAMAGUCHI ET AL., BR. J. CANCER, (1989), vol. 60, pages 382 - 84
    - ALFTHAN ET AL., CANCER RES., (1992), vol. 52, pages 4628 - 33
    - HOON ET AL., INT. J. CANCER, (1989), vol. 43, pages 857 - 62
    - ANDO ET AL., INT. J. CANCER, (1987), vol. 40, pages 12 - 17
    - TSUCHIDA ET AL., J. NATL. CANCER, (1987), vol. 78, pages 45 - 54
    - TSUCHIDA ET AL., J. NATL. CANCER, (1987), vol. 78, pages 55 - 60
    - LEHMANN ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 9891 - 95
    - LEHMANN ET AL., CANCER RES., (1987), vol. 47, pages 841 - 45
    - VIJAYASARDAHI ET AL., J. EXP. MED., (1990), vol. 171, pages 1375 - 80
    - NATALI ET AL., CANCER, (1987), vol. 59, pages 55 - 63
    - DATTA ET AL., J. CLIN. ONCOL., (1994), vol. 12, pages 475 - 82
    - XQ ET AL., SCAND J. RHEUMATOL., (2012), vol. 41, pages 413 - 420
    - BASU ET AL., J. IMMUNOLOGY, (20091211), vol. 184, pages 545 - 549
    - ABRAHAM; GIBBONS, CLIN. CANCER RES., (2007), vol. 13, no. 11, pages 3109 - 14
    - LEWIS, GENETIC ENGINEERING NEWS, (1992), vol. 12, page 1
    - GUATELLI ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 1874 - 1878
    - WEISS, SCIENCE, (1991), vol. 254, pages 1292 - 1293
    - WONG ET AL., SCIENCE, (1985), vol. 228, pages 810 - 815
    - YAO ET AL., IMMUNITY, (2011), vol. 34, pages 729 - 740
    - YAO ET AL., IMMUNITY, (2011), vol. 34, no. 5, pages 729 - 40
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.